JP2024518000A5 - - Google Patents
Info
- Publication number
- JP2024518000A5 JP2024518000A5 JP2024513163A JP2024513163A JP2024518000A5 JP 2024518000 A5 JP2024518000 A5 JP 2024518000A5 JP 2024513163 A JP2024513163 A JP 2024513163A JP 2024513163 A JP2024513163 A JP 2024513163A JP 2024518000 A5 JP2024518000 A5 JP 2024518000A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- pharmaceutically acceptable
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182728P | 2021-04-30 | 2021-04-30 | |
| US63/182,728 | 2021-04-30 | ||
| PCT/US2022/026715 WO2022232383A1 (en) | 2021-04-30 | 2022-04-28 | Small molecule modulators of glucocerebrosidase activity and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518000A JP2024518000A (ja) | 2024-04-23 |
| JP2024518000A5 true JP2024518000A5 (cg-RX-API-DMAC7.html) | 2025-05-09 |
Family
ID=83848834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513163A Pending JP2024518000A (ja) | 2021-04-30 | 2022-04-28 | グルコセレブロシダーゼ活性の小分子モジュレータ及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240262832A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4329881A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024518000A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240005805A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117642404A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022265691A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023022524A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3218259A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023012882A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022232383A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7677983B2 (ja) | 2020-01-23 | 2025-05-15 | マイオフォルテ セラピューティクス,インク. | Pgdh阻害剤、およびその作製と使用の方法 |
| CA3235270A1 (en) * | 2021-10-13 | 2023-04-20 | Vanqua Bio, Inc. | Small molecule modulators of glucocerebrosidase activity and uses thereof |
| US20250230172A1 (en) * | 2021-10-13 | 2025-07-17 | Vanqua Bio, Inc. | Small molecule modulators of glucocerebrosidase activity and uses thereof |
| CN121218985A (zh) * | 2022-12-08 | 2025-12-26 | 森雅制药有限公司 | Sarm1抑制剂、药物组合物和治疗应用 |
| WO2024158931A1 (en) * | 2023-01-25 | 2024-08-02 | Epirium Bio Inc. | Pgdh inhibitors and methods of making and using |
| WO2025171259A1 (en) * | 2024-02-09 | 2025-08-14 | Board Of Regents Of The University Of Nebraska | Compounds, compositions, and methods for the treatment of diseases |
| WO2025237303A1 (zh) * | 2024-05-14 | 2025-11-20 | 先声药业有限公司 | β-葡萄糖脑苷脂酶变构调节剂、其药物组合物及用途 |
| WO2025244978A1 (en) * | 2024-05-20 | 2025-11-27 | The General Hospital Corporation | Compounds for targeting ulk3 and uses of the same |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4088652A (en) * | 1975-07-31 | 1978-05-09 | American Cyanamid Company | Acylazabicyclohexanes |
| JPH0240671B2 (ja) * | 1982-02-05 | 1990-09-12 | Lion Corp | 11fueniruu1hhpirazoro*3*44b*pirajinjudotai |
| AUPQ105499A0 (en) * | 1999-06-18 | 1999-07-08 | Biota Scientific Management Pty Ltd | Antiviral agents |
| US7294637B2 (en) * | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| US6995144B2 (en) * | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| CA2507348C (en) * | 2004-05-13 | 2013-07-16 | The Hospital For Sick Children | Real time methylumbelliferone-based assay |
| FR2887549B1 (fr) * | 2005-06-23 | 2009-07-10 | Centre Nat Rech Scient | Nouveaux composes de la famille des iminosucres, leurs utilisations, notamment pour le traitement de maladies lysosomales, ainsi que leur procede de preparation |
| US20100222353A1 (en) * | 2006-01-27 | 2010-09-02 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
| EP1984351A1 (en) * | 2006-02-17 | 2008-10-29 | Memory Pharmaceuticals Corporation | Compounds having 5-ht6 receptor affinity |
| US20100292266A1 (en) * | 2006-05-26 | 2010-11-18 | Richard Apodaca | Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase |
| DK2040548T3 (da) * | 2006-06-23 | 2012-08-13 | Amicus Therapeutics Inc | Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase |
| AU2012200270A1 (en) * | 2007-05-23 | 2012-02-09 | Merck Sharp & Dohme Corp. | Pyridyl piperidine orexin receptor antagonists |
| CA2687931C (en) * | 2007-05-31 | 2016-05-24 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists and uses thereof |
| CN101952286A (zh) * | 2007-12-21 | 2011-01-19 | 阿斯利康(瑞典)有限公司 | 用于治疗和雄激素受体有关的病症的双环衍生物 |
| WO2010010187A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2010019392A1 (en) * | 2008-08-13 | 2010-02-18 | Merck Sharp & Dohme Corp. | Purine derivatives for treatment of alzheimer's disease |
| RU2015147509A (ru) * | 2009-10-19 | 2019-01-14 | Амикус Терапьютикс, Инк. | Новые композиции для предупреждения и/или лечения дегенеративных расстройств центральной нервной системы |
| US9051296B2 (en) * | 2009-11-16 | 2015-06-09 | Raqualia Pharma Inc. | Aryl carboxamide derivatives as TTX-S blockers |
| WO2012135631A1 (en) * | 2011-03-30 | 2012-10-04 | Arrien Pharmaeuticals Llc | Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors |
| AR090037A1 (es) * | 2011-11-15 | 2014-10-15 | Xention Ltd | Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio |
| WO2013075227A1 (en) * | 2011-11-25 | 2013-05-30 | The Hospital For Sick Children | β-GLUCOCEREBROSIDASE CHAPERONES |
| JP6454348B2 (ja) * | 2013-12-19 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | 窒素複素環誘導体およびその医薬品への応用 |
| JP2017502961A (ja) * | 2013-12-23 | 2017-01-26 | アレクトス セラピューティックス インコーポレイテッド | グルコセレブロシダーゼモジュレーターおよびその使用 |
| US20180185368A1 (en) * | 2014-11-06 | 2018-07-05 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
| WO2017004408A1 (en) * | 2015-07-01 | 2017-01-05 | Northwestern University | Substituted 4-methyl-pyrrolo[1.2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity |
| CN108290855A (zh) * | 2015-07-01 | 2018-07-17 | 西北大学 | 被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途 |
| US10154992B2 (en) * | 2016-07-12 | 2018-12-18 | The Regents Of The University Of California | Compounds and methods for treating HIV infection |
| EP3661919A4 (en) * | 2017-08-02 | 2021-03-31 | Northwestern University | SUBSTITUTED FUSION PYRIMIDINE COMPOUNDS AND THEIR USES |
| JP7052798B2 (ja) * | 2017-08-10 | 2022-04-12 | 大正製薬株式会社 | アゾールで置換されたピリジン化合物 |
| US10961341B2 (en) * | 2018-01-30 | 2021-03-30 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use |
| US10882865B2 (en) * | 2018-08-31 | 2021-01-05 | Northwestern University | Pyrrolopyrimidine compounds and uses thereof for modulating glucocerebrosidase activity |
-
2022
- 2022-04-28 CA CA3218259A patent/CA3218259A1/en active Pending
- 2022-04-28 EP EP22796720.5A patent/EP4329881A4/en active Pending
- 2022-04-28 WO PCT/US2022/026715 patent/WO2022232383A1/en not_active Ceased
- 2022-04-28 MX MX2023012882A patent/MX2023012882A/es unknown
- 2022-04-28 JP JP2024513163A patent/JP2024518000A/ja active Pending
- 2022-04-28 US US18/288,928 patent/US20240262832A1/en active Pending
- 2022-04-28 BR BR112023022524A patent/BR112023022524A2/pt unknown
- 2022-04-28 KR KR1020237041098A patent/KR20240005805A/ko active Pending
- 2022-04-28 AU AU2022265691A patent/AU2022265691A1/en active Pending
- 2022-04-28 CN CN202280046263.9A patent/CN117642404A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2594742C2 (ru) | Макроциклические соединения в качестве ингибиторов киназы trk | |
| WO2021093758A1 (zh) | 一种嘧啶并环衍生物及其在医药上的应用 | |
| WO2021249057A1 (zh) | 杂环化合物及其用途 | |
| CN108148022B (zh) | 穿心莲内酯类化合物、其药物组合物及应用 | |
| JP6407950B2 (ja) | Ship1モジュレーターおよびそれに関連する組成物および方法 | |
| CN108623615A (zh) | 吡唑[3,4-d]嘧啶-3-酮的大环衍生物、其药物组合物及应用 | |
| JP2022507724A (ja) | 抗ウイルス剤としての官能化複素環 | |
| WO2019143902A2 (en) | Substituted heterocycles as antiviral agents | |
| CN109384803B (zh) | Atx抑制剂及其制备方法和应用 | |
| TW201111385A (en) | Heterocyclic compounds as janus kinase inhibitors | |
| CN110028475A (zh) | 基于苯并呋喃结构的新型cdk9抑制剂、其制备方法及应用 | |
| TW201936572A (zh) | 芳基醚及其用途 | |
| JP2005535731A5 (cg-RX-API-DMAC7.html) | ||
| TW202024093A (zh) | 作為抗病毒劑之官能化雜環 | |
| JP2013530951A (ja) | ヤヌスキナーゼ阻害剤としてのヘテロ環式化合物 | |
| TW202527933A (zh) | 咪唑-2-酮衍生物及其在醫藥上的應用 | |
| CN112028870A (zh) | 一种具有苄氧基芳环结构的化合物,其制备方法和用途 | |
| CN115867545A (zh) | 抗病毒素1,3-二氧代茚化合物 | |
| CN118119594A (zh) | 一种喜树碱类衍生物中间体、其制备方法和用途 | |
| JP2025520541A (ja) | コロナウイルス感染症の治療のための化合物 | |
| KR20240024906A (ko) | 설폭시민 화합물 및 이의 용도 | |
| RU2530775C2 (ru) | ПРОИЗВОДНЫЕ 1Н-ПИРАЗОЛО[4,3-c]ИЗОХИНОЛИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| KR20200112810A (ko) | 헤테로아릴 아미드 화합물, 이에 대한 제조 방법, 이의 약학적 조성물 및 이의 적용 | |
| ES2432525T3 (es) | Pirroles sustituidos terapéuticos | |
| WO2020156522A1 (zh) | 地佐辛衍生物及其医药用途 |